16423 studies found for:    Open Studies | "Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Early Detection of Pancreatic Cystic Neoplasms
Conditions: Pancreatic Cysts;   Intraductal Papillary Mucinous Neoplasm;   Pancreatic Mucinous-Cystic Neoplasm;   Cystic, Mucinous and/or Serous Neoplasm;   Solid Pseudopapillary Tumour of the Pancreas
Intervention:
22 Recruiting Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Conditions: Germ Cell Neoplasms;   Testicular Neoplasms;   Non Seminomatous Germ Cell Tumors;   Mediastinal Neoplasms;   Genital Neoplasms, Male;   Genital Neoplasms, Female;   Ovarian Neoplasms
Intervention: Drug: Pembrolizumab
23 Unknown  Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis;   Liver Neoplasms
Interventions: Drug: 5-FU and oxaliplatin;   Procedure: colorectal cancer resection+ adjuvant chemotherapy (mFOLFOX6)
24 Recruiting Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors.
Conditions: Small Cell Lung Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Stomach Neoplasms;   Triple Negative Breast Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Esophagogastric Junction Neoplasms
Interventions: Drug: paclitaxel + carboplatin;   Drug: carboplatin + etoposide;   Drug: gemcitabine + carboplatin;   Drug: nab-paclitaxel (paclitaxel-albumin) + carboplatin;   Drug: oxaliplatin + 5-fluorouracil (5FU) + leucovorin (calcium folinate/folinic acid);   Biological: durvalumab;   Biological: tremelimumab
25 Recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions)
Conditions: Breast Cancer;   Cholangiocarcinoma;   Colorectal Cancer;   Head and Neck Neoplasms;   Lymphoma, Large-Cell, Anaplastic;   Melanoma;   Neuroendocrine Tumors;   Non-Small Cell Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer;   Papillary Thyroid Cancer;   Primary Brain Tumors;   Renal Cell Carcinoma;   Sarcomas;   Salivary Gland Cancers;   Adult Solid Tumor
Intervention: Drug: Entrectinib
26 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems
27 Recruiting Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Conditions: AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
28 Recruiting Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Conditions: Prostatic Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Melanoma;   Leukemia
Intervention: Behavioral: Interactive Voice Response (IVR) Reminders
29 Recruiting Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively
Conditions: Breast Neoplasms;   Lung Neoplasms;   Colorectal Neoplasms;   Stomach Neoplasms
Interventions: Behavioral: Online health management program;   Behavioral: Health coaching;   Behavioral: Workshop;   Behavioral: Standard health educational booklet
30 Recruiting Precise Treatment in Hepatobiliary Cancers (PTHBC)
Conditions: Liver Neoplasms;   Biliary Tract Neoplasms;   Hepatobiliary Neoplasms
Intervention: Genetic: Precise treatment
31 Recruiting DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries
Conditions: Ovarian Neoplasms;   Endometrial Neoplasms;   Endometrial Cancer;   Ovarian Cancer;   Screening;   Safety;   Reduced Mortality;   Reduced Morbidity;   Early Diagnosis
Intervention:
32 Recruiting Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Conditions: Ewing's Family Tumors;   Renal Tumors;   Hepatoblastoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma;   Primary Malignant Brain Neoplasms;   Retinoblastoma;   Medulloblastoma;   Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET);   Atypical Teratoid/Rhabdoid Tumor (AT/RT);   CNS Tumors;   Germ Cell Tumors
Interventions: Drug: Ifosfamide;   Drug: Etoposide;   Drug: Mesna;   Biological: G-CSF;   Drug: Busulfan;   Drug: Melphalan;   Drug: Thiotepa;   Biological: Autologous stem cell infusion;   Radiation: Radiation;   Drug: Carboplatin;   Drug: Paclitaxel;   Procedure: Leukapheresis
33 Recruiting Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis
Conditions: Malignant Neoplasm of Stomach;   Secondary Malignant Neoplasm of Peritoneum;   Secondary Malignant Neoplasm of Other and Unspecified Sites
Intervention: Procedure: HIPEC
34 Not yet recruiting A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Conditions: Gynecologic Neoplasms;   Epithelial Ovarian Cancer;   Uterine Endometrial Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Pembrolizumab
35 Recruiting Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging
Conditions: Neoplasms;   Colorectal Neoplasms;   Rectal Diseases;   Gastrointestinal Neoplasms
Intervention:
36 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
37 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:
38 Recruiting Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
Conditions: Pancreatic Cancer;   Neoplasm
Intervention:
39 Recruiting PERCIST Criteria for Response Evaluation With Solid Tumors
Conditions: Lung Neoplasms;   Breast Neoplasms;   Colonic Neoplasms;   Lymphoma
Intervention: Other: drug&radiation
40 Recruiting A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms by Histologic Type;   Neoplasms;   Clear-cell Metastatic Renal Cell Carcinoma;   Melanoma;   Triple Negative Breast Cancer;   Bladder Cancer;   Head and Neck Cancer;   Non-small Cell Lung Cancer
Intervention: Drug: Combination of Varlilumab and Atezolizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years